Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J.

J Natl Compr Canc Netw. 2017 Jan;15(1):92-120.

PMID:
28040721
2.

Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.

Bodurtha Smith AJ, Fader AN, Tanner EJ.

Am J Obstet Gynecol. 2017 May;216(5):459-476.e10. doi: 10.1016/j.ajog.2016.11.1033. Epub 2016 Nov 18. Review.

PMID:
27871836
3.

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management.

Beavis AL, Smith AJ, Fader AN.

Int J Womens Health. 2016 May 23;8:151-67. doi: 10.2147/IJWH.S88367. eCollection 2016. Review.

4.

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer.

Angarita AM, Johnson CA, Fader AN, Christianson MS.

Front Oncol. 2016 Apr 25;6:102. doi: 10.3389/fonc.2016.00102. eCollection 2016. Review.

5.

Trans-surgical Disciplines Collaboration Is an Effective Strategy for Expediting Quality Improvement.

Wick EC, Pronovost PJ, Fader AN.

Ann Surg. 2016 Dec;264(6):915-916. No abstract available.

PMID:
27140511
6.

An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.

Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J.

J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):303-8. doi: 10.1016/j.jmig.2015.12.012. Epub 2016 Jan 8. No abstract available.

PMID:
26773577
7.

Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.

Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2015 Nov;13(11):1321-31.

PMID:
26553763
8.

Lifestyle and Weight Management Counseling in Uterine Cancer Survivors: A Study of the Uterine Cancer Action Network.

Tseng JH, Roche KL, Jernigan AM, Salani R, Bristow RE, Fader AN.

Int J Gynecol Cancer. 2015 Sep;25(7):1285-91. doi: 10.1097/IGC.0000000000000475.

PMID:
25966932
9.

Cervical Cancer, Version 2.2015.

Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR 3rd, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL.

J Natl Compr Canc Netw. 2015 Apr;13(4):395-404; quiz 404.

PMID:
25870376
10.

Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all.

Groen RS, Gershenson DM, Fader AN.

Gynecol Oncol. 2015 Feb;136(2):373-83. doi: 10.1016/j.ygyno.2014.11.078. Epub 2014 Dec 3. Review.

PMID:
25481800
11.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.

Cripe J, Tseng J, Eskander R, Fader AN, Tanner E, Bristow R.

Ann Surg Oncol. 2015 Feb;22(2):655-61. doi: 10.1245/s10434-014-4026-6. Epub 2014 Aug 26.

PMID:
25155402
12.

Laparoendoscopic single-site surgery for management of ovarian endometriomas.

Bedaiwy MA, Farghaly T, Hurd W, Liu J, Mansour G, Fader AN, Escobar P.

JSLS. 2014 Apr-Jun;18(2):191-6. doi: 10.4293/108680813X13794522666284.

13.

Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study.

Eskander RN, Osann K, Dickson E, Holman LL, Rauh-Hain JA, Spoozak L, Wu E, Krill L, Fader AN, Tewari KS.

Gynecol Oncol. 2014 Aug;134(2):379-84. doi: 10.1016/j.ygyno.2014.05.021. Epub 2014 Jun 2.

14.

A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.

Sinno AK, Fader AN, Roche KL, Giuntoli RL 2nd, Tanner EJ.

Gynecol Oncol. 2014 Aug;134(2):281-6. doi: 10.1016/j.ygyno.2014.05.022. Epub 2014 Jun 2.

PMID:
24882555
15.

Uterine neoplasms, version 1.2014.

Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR 3rd, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2014 Feb;12(2):248-80.

PMID:
24586086
16.

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.

Fader AN, Java J, Krivak TC, Bristow RE, Tergas AI, Bookman MA, Armstrong DK, Tanner EJ, Gershenson DM.

Gynecol Oncol. 2014 Mar;132(3):560-5. doi: 10.1016/j.ygyno.2013.11.016. Epub 2013 Dec 13.

17.

Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.

Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ.

Gynecol Oncol. 2014 Jan;132(1):33-7. doi: 10.1016/j.ygyno.2013.11.033. Epub 2013 Dec 4.

PMID:
24316307
18.

High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes.

Doll KM, Tseng J, Denslow SA, Fader AN, Gehrig PA.

Gynecol Oncol. 2014 Jan;132(1):44-9. doi: 10.1016/j.ygyno.2013.10.023. Epub 2013 Oct 29.

PMID:
24183734
19.

Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer.

Boruta DM, Fagotti A, Bradford LS, Escobar PF, Scambia G, Kushnir CL, Michener CM, Fader AN.

J Minim Invasive Gynecol. 2014 May-Jun;21(3):394-8. doi: 10.1016/j.jmig.2013.10.005. Epub 2013 Oct 23.

PMID:
24161887
20.

Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN.

Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7.

PMID:
24016408

Supplemental Content

Loading ...
Support Center